Beijing Succeeder Technology Inc.

Shanghai Stock Exchange 688338.SS

Beijing Succeeder Technology Inc. Free Cash Flow for the year ending December 31, 2023: USD -1.49 M

Beijing Succeeder Technology Inc. Free Cash Flow is USD -1.49 M for the year ending December 31, 2023, a -411.16% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Beijing Succeeder Technology Inc. Free Cash Flow for the year ending December 31, 2022 was USD 479.15 K, a -96.68% change year over year.
Beijing Succeeder Technology Inc. Free Cash Flow for the year ending December 31, 2021 was USD 14.43 M, a 135.57% change year over year.
Beijing Succeeder Technology Inc. Free Cash Flow for the year ending December 31, 2020 was USD 6.12 M, a -23.62% change year over year.
Beijing Succeeder Technology Inc. Free Cash Flow for the year ending December 31, 2019 was USD 8.02 M, a 1.56% change year over year.

Key data

Date	Free Cash Flow	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities

Shanghai Stock Exchange: 688338.SS

Beijing Succeeder Technology Inc.

CEO	Mr. Hai Wang
IPO Date	Aug. 6, 2020
Location	China
Headquarters	Tower 1A
Employees	296
Sector	Health Care
Industries Biotechnology Chemicals & Advanced Materials Medical Instruments Pharmaceuticals

Description

Beijing Succeeder Technology Inc. engages in the research and development, manufacture, and sale of in-vitro diagnostic products in China and internationally. Its products include coagulation analyzers and reagents, blood rheology analyzers, ESR analyzers, and platelet aggregation analyzers. The company was founded in 2003 and is headquartered in Beijing, China.

Key trends

Past 5 years